Targeted T-Cell Therapy Beneficial in Rare Form of Melanoma

Patients with uveal melanoma may respond to T-cell therapy directed at an antigen that is highly expressed in the tumors, despite them not being amenable to traditional immunotherapy, suggests trial.
Medscape Medical News